Drug and therapeutics bulletin

Drug Ther Bull · ISSN (print) 0012-6543 · 6 papers in corpus
review 1999
doi:10.1136/dtb.1999.37425 ·PMID:10563061

Various estimates suggest that 6-44% of women of reproductive age have endometriosis, that is, functioning endometrial tissue lying outside its usual intrauterine location. Although this condition may be asymptomatic, common symptoms includ…

article 1993
doi:10.1136/dtb.31.22.88-b

In this article we gave the cost of 6 months’ treatment with progestagens as that based on norethisterone. However, our main reference was to a comparative study in which 100mg of medroxyprogesterone acetate daily showed equivalent efficacy…

article 1993
doi:10.1136/dtb.31.6.21 ·PMID:8348882

Gonadotropin releasing hormone (GnRH) analogues are now marketed in the UK for the treatment of patients with endometriosis. Endometriosis is an oestrogen-dependent disorder, and conventional medical treatments have relied on mechanisms tha…

article 1991
doi:10.1136/dtb.29.12.45-a ·PMID:1935583

A year ago we concluded that danazol is effective in relieving the symptoms of endometriosis, but is of less certain value in helping any associated infertility. 1

article 1990
doi:10.1136/dtb.28.6.22 ·PMID:2130010

The indications for danazol (Danol - Winthrop) have widened and the dose regimens have changed since our last review. 1 Current indications include endometriosis, menorrhagia, benign cystic breast disease and premenstrual symptoms.

article 1975
doi:10.1136/dtb.13.24.94 ·PMID:1192947

Danazol (Danol - Winthrop) is a semisynthetic steroid, derived from 17-α-ethinyl testosterone (ethisterone) which inhibits pituitary gonadotropin secretion, probably by inhibiting both synthesis and release. It has no oestrogenic or progest…